{"id":"W2330784951","doi":"10.1212/wnl.78.1_meetingabstracts.s01.007","title":"Clinical Efficacy of Laquinimod for the Treatment of Multiple Sclerosis; Pooled Analyses from the ALLEGRO and BRAVO Phase III Trials (S01.007)","year":2012,"lang":"en","type":"article","venue":"Neurology","topic":"Pediatric health and respiratory diseases","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"NeuroRx Research (Canada)","funders":"","keywords":"Medicine; Placebo; Clinical endpoint; Multiple sclerosis; Expanded Disability Status Scale; Discontinuation; Internal medicine; Randomized controlled trial; Atrophy; Physical therapy; Pathology; Psychiatry; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02490765,0.00210446,0.007778137,0.001489649,0.0002939616,0.001848802,0.0008153741,0.001437252,0.002737339],"category_scores_gemma":[0.01704185,0.0007672072,0.01304547,0.001638562,0.0005359016,0.0009327977,0.0009108295,0.001563852,0.0003395071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006176876,"about_ca_system_score_gemma":0.0008582629,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009763876,"about_ca_topic_score_gemma":0.002064799,"domain_scores_codex":[0.9848726,0.01165151,0.001272696,0.001024568,0.0009243902,0.0002543329],"domain_scores_gemma":[0.988316,0.006605552,0.003200779,0.0008124359,0.0007155459,0.0003496433],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.4192748,0.0002980055,0.01183925,0.0163331,0.5132909,0.0001176049,0.00008495201,0.001874765,0.002791168,0.0001558902,0.002993908,0.03094563],"study_design_scores_gemma":[0.2540863,0.02981205,0.07099673,0.001835608,0.6314734,0.0003555486,0.0001118682,0.002246938,0.001488534,0.0007592874,0.006675689,0.0001578767],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.4580016,0.5059765,0.009603238,0.001499168,0.001277914,0.004135953,0.01310714,0.000582061,0.005816409],"genre_scores_gemma":[0.9480828,0.03612864,0.003944327,0.001121752,0.0008836507,0.002593867,0.005745092,0.0001259886,0.001373857],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02490765,"threshold_uncertainty_score":0.1317258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.4610587721992019,"score_gpt":0.5556379054988179,"score_spread":0.09457913329961598,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}